Company: PFSA
Filing Date: 2025-05-09
Form Type: S-4/A
Source: 0001213900-25-041151
Chunk: 221

Company: Profusa, Inc.
Filing Date: 2025-05-09
Form: S-4/A
Chunk 221
---
 the special meeting of stockholders. •The Sponsor also beneficially owns 5,162,500 warrants, for which It paid $5,162,500 and which will expire and be worthless if NorthView does not complete a business combination within the applicable time period. •NorthView’s officers and directors have an aggregate of $560,833 invested in the Sponsor, which will be lost in the event that the Business Combination is not approved and concluded. •Certain of NorthView’s officers and directors have invested an aggregate of $115,000 into Profusa’s Bridge Notes, which will be converted into shares of Profusa and exchanged for shares of New Profusa Common Stock in connection with the Merger. •NorthView’s directors will not receive reimbursement for the out -of-pocketexpenses ($22,650 as of the date hereof) incurred by them on NorthView’s behalf incident to identifying, investigating and consummating a business combination, unless a business combination is consummated. •Up to an aggregate amount of $2,500,000 of any amounts outstanding under any working capital loans made by Sponsor or any of its affiliates to NorthView may be converted into warrants to purchase New Profusa Common Stock at a price of $1.00 per warrant at the option of the lender. As of the date of this proxy statement/prospectus there were no amounts outstanding under such working capital loans, however, the Sponsor held a convertible promissory note in the amount of $1,919,796, convertible at a price of $2.22. •The Sponsor and its affiliates can earn a positive rate of return on their investments, even if the holders of NorthView public shares experience a negative rate of return on their investments in NorthView and New Profusa. •Fred Knechtel is currently expected to continue as Chief Financial Officer of New Profusa, and certain other NorthView officers and directors could potentially continue as officers and/or directors of New Profusa if the Business Combination is completed. •Because the Sponsor and the NorthView directors will benefit from the completion of a business combination, they may be incentivized to recommend and complete a business combination of a less favorable target company or on terms less favorable to NorthView stockholders, rather than liquidate NorthView. •NorthView would be unable to indemnify its current directors and officers or continue to provide directors’ and officers’ liability insurance unless the Business Combination is completed. •In addition, I -Bankersand Dawson James, the managing underwriters of NorthView’s